Overview

Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose is to demonstrate a correction of anemia in hepatitis C virus treatment with peginterferon plus ribavirin.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Angers
Treatments:
Epoetin Alfa
Peginterferon alfa-2a
Ribavirin